Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 668

1.

The role of spatial information in the preservation of the shrimp nursery function of mangroves: a spatially explicit bio-economic model for the assessment of land use trade-offs.

Zavalloni M, Groeneveld RA, van Zwieten PA.

J Environ Manage. 2014 Oct 1;143:17-25. doi: 10.1016/j.jenvman.2014.04.020. Epub 2014 May 13.

PMID:
24833524
2.

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, Zanchetti A.

Blood Press. 2009;18(6):308-47. doi: 10.3109/08037050903450468. No abstract available.

PMID:
20001654
3.

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A; European Society of Hypertension.

J Hypertens. 2009 Nov;27(11):2121-58. doi: 10.1097/HJH.0b013e328333146d. No abstract available.

PMID:
19838131
4.

Do we need new antihypertensive treatments?

Van Zwieten PA.

Blood Press. 2007;16(5):291-300. Review. No abstract available.

PMID:
17934916
5.

Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure.

de Groot AA, Mathy MJ, van Zwieten PA, Peters SL.

J Cardiovasc Pharmacol. 2007 Jul;50(1):56-60.

PMID:
17666916
6.

The sympathetic nervous system and the metabolic syndrome.

Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA.

J Hypertens. 2007 May;25(5):909-20. Review.

PMID:
17414649
7.
8.

Background and treatment of metabolic syndrome: a therapeutic challenge.

van Zwieten PA, Mancia G.

Semin Cardiothorac Vasc Anesth. 2006 Sep;10(3):206-14. Review.

PMID:
16959752
9.

The metabolic syndrome - background and treatment.

van Zwieten PA.

Neth Heart J. 2006 Sep;14(9):301-308. Review.

10.

Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.

Streefkerk JO, van Zwieten PA.

Auton Autacoid Pharmacol. 2006 Apr;26(2):141-8. Review.

PMID:
16553642
11.

The statins: similarities and differences.

van Zwieten PA.

Neth Heart J. 2006 Mar;14(3):79-80. No abstract available.

12.

Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.

Wonnemann M, Schug B, Schmücker K, Brendel E, van Zwieten PA, Blume H.

Int J Clin Pharmacol Ther. 2006 Jan;44(1):38-48.

PMID:
16425970
13.

Combination of antihypertensive drugs from a historical perspective.

van Zwieten PA, Farsang C.

Blood Press. 2005;14(2):72-9. Review. No abstract available.

PMID:
16036483
14.

Antihypertensive drugs interacting with central imidazoline (I1)-receptors.

van Zwieten PA.

Expert Opin Investig Drugs. 1998 Nov;7(11):1781-93.

PMID:
15991929
15.

BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.

Falcão LM, Pinto F, Ravara L, van Zwieten PA.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):121-9.

PMID:
15526247
16.

AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease.

Nap A, Balt JC, Mathy MJ, Van Zwieten PA.

Auton Autacoid Pharmacol. 2003 Oct-Dec;23(5-6):285-96. Review.

PMID:
15255813
17.

[Recently published European and American guidelines for the diagnosis and treatment of hypertension].

van Zwieten PA, Struijker Boudier HA, de Leeuw PW.

Ned Tijdschr Geneeskd. 2004 May 1;148(18):868-71. Dutch.

PMID:
15152386
18.

The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.

Nap A, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.

Fundam Clin Pharmacol. 2004 Jun;18(3):309-19.

PMID:
15147282
19.

The SYST-EUR study and beyond: immediate versus delayed treatment of isolated systolic hypertension.

van Zwieten PA; SYST-EUR Study.

J Hypertens. 2004 Apr;22(4):689-90. No abstract available.

PMID:
15126908
20.

Beneficial combinations of two or more antihypertensive agents.

van Zwieten PA, Farsang C.

Blood Press. 2004;13(1):62-3. Review. No abstract available.

PMID:
15083643
21.

Different prejunctional and postjunctional responses to angiotensin II and AT1-receptor inhibition: influence of maturation.

Nap A, Mathy MJ, Pfaffendorf M, van Zwieten PA.

J Cardiovasc Pharmacol. 2004 Mar;43(3):432-9.

PMID:
15076228
22.

Vasopressin facilitates presynaptic sympathetic nerve activity in humans.

Streefkerk JO, Balt JC, van Montfrans GA, van Lieshout JJ, Pfaffendorf M, van Zwieten PA.

J Hypertens. 2004 Mar;22(3):551-5.

PMID:
15076161
23.

Interactions between antihypertensive agents and other drugs.

van Zwieten PA, Farsang C.

Blood Press. 2003;12(5-6):351-2. No abstract available.

PMID:
14763670
24.

Vasopressin-induced vasoconstriction is dependent on MAPKerk1/2 phosphorylation.

Streefkerk JO, Hoogaars WM, Christoffels VM, Sand C, Pfaffendorf M, Peters SL, Van Zwieten PA.

Fundam Clin Pharmacol. 2004 Feb;18(1):45-50.

PMID:
14748753
25.
26.

Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.

Nap A, Belterman CN, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.

J Renin Angiotensin Aldosterone Syst. 2003 Dec;4(4):220-7.

PMID:
14689369
27.

Involvement of reactive oxygen species in angiotensin II-induced vasoconstriction.

de Groot AA, van Zwieten PA, Peters SL.

J Cardiovasc Pharmacol. 2004 Jan;43(1):154-9.

PMID:
14668582
28.

Antioxidant activity of nebivolol in the rat aorta.

de Groot AA, Mathy MJ, van Zwieten PA, Peters SL.

J Cardiovasc Pharmacol. 2004 Jan;43(1):148-53.

PMID:
14668581
29.

Different AT1 receptor subtypes at pre- and postjunctional sites: AT1A versus AT1B receptors.

Nap A, Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.

J Cardiovasc Pharmacol. 2004 Jan;43(1):14-20.

PMID:
14668562
30.
31.

Endothelium-dependent, vasopressin-induced contractions in rabbit renal arteries.

Streefkerk JO, Pfaffendorf M, van Zwieten PA.

J Cardiovasc Pharmacol. 2003 Dec;42(6):703-9.

PMID:
14639090
32.

Vasopressin-induced facilitation of adrenergic responses in the rat mesenteric artery is V1-receptor dependent.

Streefkerk JO, Pfaffendorf M, van Zwieten PA.

Auton Autacoid Pharmacol. 2003 Feb;23(1):35-41.

PMID:
14565536
33.

Hydrogen sulphide: not only foul smelling, but also pathophysiologically relevant.

van Zwieten PA.

J Hypertens. 2003 Oct;21(10):1819-20. Review. No abstract available.

PMID:
14508184
34.

Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta.

de Groot AA, Mathy MJ, van Zwieten PA, Peters SL.

J Cardiovasc Pharmacol. 2003 Aug;42(2):232-6.

PMID:
12883327
35.

Pre- and postsynaptic inhibitory potencies of the angiotensin AT1 receptor antagonists eprosartan and candesartan.

Nap A, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.

Eur J Pharmacol. 2003 May 23;469(1-3):117-24.

PMID:
12782193
36.

The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation.

Sand C, Peters SL, Pfaffendorf M, van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):635-9. Epub 2003 May 6.

PMID:
12732926
37.

Effects of hypochlorite and hydrogen peroxide on cardiac autonomic receptors and vascular endothelial function.

Sand C, Peters SL, Pfaffendorf M, van Zwieten PA.

Clin Exp Pharmacol Physiol. 2003 Apr;30(4):249-53.

PMID:
12680842
38.

Influence of the nature of pre-contraction on the responses to commonly employed vasodilator agents in rat-isolated aortic rings.

Streefkerk JO, de Groot AA, Pfaffendorf M, van Zwieten PA.

Fundam Clin Pharmacol. 2002 Dec;16(6):485-94.

PMID:
12685507
39.

Decreased facilitation by angiotensin II of noradrenergic neurotransmission in isolated mesenteric artery of rabbits with chronic heart failure.

Balt JC, Belterman CN, Mathy MJ, Nap A, Baartscheer A, Pfaffendorf M, Van Zwieten PA.

J Cardiovasc Pharmacol. 2003 Mar;41(3):356-62.

PMID:
12605013
40.

Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.

Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.

Fundam Clin Pharmacol. 2003 Feb;17(1):83-91.

PMID:
12588634
41.

The effects of hypochlorite-induced oxidative stress on presynaptic M2-receptors at sympathetic nerve endings in the rat tail artery.

Sand C, Peters SL, Mathy MJ, Pfaffendorf M, van Zwieten PA.

Auton Autacoid Pharmacol. 2002 Apr;22(2):127-32.

PMID:
12568130
42.

Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.

Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.

J Renin Angiotensin Aldosterone Syst. 2002 Sep;3(3):181-7.

PMID:
12563569
44.

Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta.

Nap A, Balt JC, Pfaffendorf M, Van Zwieten PA.

J Hypertens. 2002 Sep;20(9):1821-8.

PMID:
12195125
45.

Sympatho-inhibitory properties of various AT1 receptor antagonists.

Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.

J Hypertens Suppl. 2002 Jun;20(5):S3-11.

PMID:
12184061
46.

AT1 blockers: are there alternative pathways reducing cardiovascular risk? Introduction.

van Zwieten PA, Julius S.

J Hypertens Suppl. 2002 Jun;20(5):S1. No abstract available.

PMID:
12184058
47.
48.

Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure.

de Milliano PA, de Groot AC, Tijssen JG, van Eck-Smit BL, Van Zwieten PA, Lie KI.

Am Heart J. 2002 Aug;144(2):E3.

PMID:
12177661
49.

A mitogen-activated protein kinase is involved in the inotropic but not chronotropic actions of adrenoceptor agonists and endothelin-1.

Peters SL, Sand C, Michel MC, Pfaffendorf M, Van Zwieten PA.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Aug;366(2):189-91. Epub 2002 May 22.

PMID:
12122507
50.

Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.

Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.

J Cardiovasc Pharmacol. 2002 Jul;40(1):50-7.

PMID:
12072577

Supplemental Content

Loading ...
Support Center